已核实 DOI PubMed 相关产品: 0

Carboxymethyl chitosan crosslinked self-assembled collagen hydrogel protects against radiation-induced skin injury by modulating iron homeostasis

Journal 2026 · IF 6.7 · 发表于 2026 年 5 月 11 日
作者: Jing Dai,Huihui Jiang,Yueyue Nie,Qin Song,Peifeng Zhao,Xinyu Huang,Beini Sheng,Qinghua Liu,Mingliang Tang,Hongmei Tang,Jihua Nie,Miao Xiao
阅读全文 在 PubMed 查看

摘要

Developed a crosslinker-free injectable hydrogel from shad scale-derived type I collagen and carboxymethyl chitosan with excellent biocompatibility. • Exhibits multi-targeted efficacy against RSI by concurrently scavenging ROS, inhibiting ferroptosis and restoring vascular perfusion. • Suppresses oxidative stress and ferroptosis via activation of the GPX4-SLC7A11 pathway. Radiation-induced skin injury (RSI) is a critical complication of radiotherapy, affecting over 95% of patients and causing severe morbidity with treatment interruptions. Clinical therapies fail to address its multifactorial pathogenesis, including vascular dysfunction, oxidative stress, and chronic inflammation. Current clinical chitosan-based wound care materials face challenges like rapid degradation and insufficient mechanical stability. To tackle these, we developed a self-assembled carboxymethyl chitosan-crosslinked collagen hydrogel (Col+CMC) using traceable type I collagen from shad fish scales. This hydrogel forms a stable, porous hydrogel at physiological conditions without external crosslinkers, integrating collagen's structural support with carboxymethyl chitosan's iron-chelating properties. In a murine RSI model, Col+CMC accelerated ulcer repair by promoting collagen remodeling and endothelial angiogenesis, while suppressing oxidative stress and ferroptosis through activation of the GPX4-SLC7A11 pathway. In vitro studies confirmed its robust free radical scavenging capacity and pro-angiogenic effects on endothelial cells. The injectable, self-setting design offers clinical advantages: no crosslinking agents simplify application, traceable aquaculture-derived collagen ensures regulatory compliance, and the composite architecture enables multi-targeted therapy against RSI's pathological drivers. This work presents a biomaterial platform that merges self-assembly functionality with mechanistic targeting of iron homeostasis, addressing critical gaps in RSI management and showcasing translational potential for radiation therapy complications. Download: Download high-res image (124KB) Download: Download full-size image